Status:
UNKNOWN
Clinical Study of Phage Therapy for Chronic Constipation Efficacy and Safety
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Pib Specific Phage
Intractable Constipation
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The overall aim was to evaluate the efficacy of PiB-specific phages for the treatment of refractory constipation through clinical studies, primarily for the publication of scientific papers and to gui...
Eligibility Criteria
Inclusion
- Patients of both sexes, aged 18-70 years, with confirmed chronic constipation and positive fecal bacteria test for PIB, agreed to participate in this experiment and signed an informed consent.
Exclusion
- Severe heart failure, hypertension, cerebrovascular disease (e.g. stroke, moyamoya disease, etc.); Secondary constipation caused by psychotropic drug abuse; Pregnant or lactating women.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05973721
Start Date
July 1 2023
End Date
October 1 2023
Last Update
August 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Tenth People's Hospital
Shanghai, China